Translational lung cancer research
Retrospective evaluation of anti-angiogenic and immune checkpoint inhibitor combination therapy in SMARCA4-deficient thoracic tumors: efficacy, safety, and biomarker considerations.
Beibei Liu, Danni Wang, Yujing Li, Fangfei Qian, Yanwei Zhang, Lele Zhang, Xinwei Wu, Xuemei Liu, Wenyan Ma, Wei Zhang, Lvkan Weng, Yuqing Lou, Rong Li
Published: 202510.21037/tlcr-2025-aw-1136
No abstract available for this study.